Drugs / Synergy I
last change Dec 2008 re-read 3 minutes ago

Synergy I

Other / unclassified

Developed for
Crohn disease
Investigated by
University of Dundee

Trials 1

2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT00305409 Jun 2006 → Dec 2008 Crohn disease University of Dundee Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Synergy I ClinicalTrials.gov intervention name — accepted as the source's own label NCT00305409 ↗
Action Inhibit “down-regulate TNF-alpha and other pro-inflammatory cytokines” NCT00305409 ↗
Modality Other / unclassified “a synbiotic, comprised on inulin and a bifidobacterial probiotic” NCT00305409 ↗